Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway

European Journal of Immunology

Volumn 44, Issue 7, 2014, Pages 2153-2164

  Sun, Lei ^a   Zhu, Ziyan ^a   Cheng, Ni ^b   Yan, Qian ^a   Ye, Richard D ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

IL 33; IRF7; Macrophages; Serum amyloid A

Indexed keywords

IL-33; IRF7; MACROPHAGES; SERUM AMYLOID A;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; INTERFERON REGULATORY FACTOR-7; INTERLEUKINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 2;

EID: 84904402074     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344310     Document Type: Article

References (41)

1. Baekkevold, E. S., Roussigne, M., Yamanaka, T., Johansen, F. E., Jahnsen, F. L., Amalric, F., Brandtzaeg, P. et al., Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J. Pathol. 2003. 163: 69-79.
2. Arend, W. P., Palmer, G. and Gabay, C., IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 2008. 223: 20-38.
3. Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G. and Girard, J. P., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad Sci. USA 2007. 104: 282-287.
4. Ohno, T., Oboki, K., Kajiwara, N., Morii, E., Aozasa, K., Flavell, R. A., Okumura, K. et al., Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 2009. 183: 7890-7897.
5. Talabot-Ayer, D., Lamacchia, C., Gabay, C. and Palmer, G., Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 2009. 284: 19420-19426.
6. Luthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G. et al., Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009. 31: 84-98.
7. Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S. and Kastelein, R. A., IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 2007. 179: 2551-2555.
8. Liew, F. Y., Pitman, N. I. and McInnes, I. B., Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010. 10: 103-110.
9. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479-490.
10. Nile, C. J., Barksby, E., Jitprasertwong, P., Preshaw, P. M. and Taylor, J. J., Expression and regulation of interleukin-33 in human monocytes. Immunology 2010. 130: 172-180.
11. Uhlar, C. M. and Whitehead, A. S., Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999. 265: 501-523.
12. Jabor, A., Holub, Z., Franekova, J., Pavlisova, M., Boril, P., Fenclova, E. and Kliment, L., Serum amyloid A as an effective marker for the assessment of surgical trauma and risk of post-operative complications. Ceska Gynekol. 2006. 71: 131-136.
13. Lannergard, A., Viberg, A., Cars, O., Karlsson, M. O., Sandstrom, M. and Larsson, A., The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy. Scand. J. Infect. Dis. 2009. 41: 663-671.
14. Uhlar, C. M., Grehan, S., Steel, D. M., Steinkasserer, A. and Whitehead, A. S., Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1 beta and TNF-alpha compared to IL-6. J. Immunol. Methods 1997. 203: 123-130.
15. Ishii, W., Matsuda, M., Nakamura, A., Nakamura, N., Suzuki, A. and Ikeda, S., Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis. Intern. Med. 2003. 42: 800-805.
16. King, V. L., Thompson, J. and Tannock, L. R., Serum amyloid A in atherosclerosis. Curr. Opin. Lipidol. 2011. 22: 302-307.
17. Zhao, Y., He, X., Shi, X., Huang, C., Liu, J., Zhou, S. and Heng, C. K., Association between serum amyloid A and obesity: a meta-analysis and systematic review. Inflamm. Res. 2010. 59: 323-334.
18. Du, J. L., Liu, J. F., Men, L. L., Yao, J. J., Sun, L. P., Sun, G. H., Song, G. R. et al., Effects of five-year intensive multifactorial intervention on the serum amyloid A and macroangiopathy in patients with short-duration type 2 diabetes mellitus. Chin. Med. J. 2009. 122: 2560-2566.
19. Connolly, M., Marrelli, A., Blades, M., McCormick, J., Maderna, P., Godson, C., Mullan, R. et al., Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J. Immunol. 2010. 184: 6427-6437.
20. Artl, A., Marsche, G., Lestavel, S., Sattler, W. and Malle, E., Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler. Thromb. Vasc. Biol. 2000. 20: 763-772.
21. Sandri, S., Rodriguez, D., Gomes, E., Monteiro, H. P., Russo, M. and Campa, A., Is serum amyloid A an endogenous TLR4 agonist? J. Leukoc. Biol. 2008. 83: 1174-1180.
22. Su, S. B., Gong, W., Gao, J. L., Shen, W., Murphy, P. M., Oppenheim, J. J. and Wang, J. M., A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 1999. 189: 395-402.
23. Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Kurlander, R., Chen, Z., Kimelman, M. L., Remaley, A. T. et al., Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 2005. 280: 8031-8040.
24. Cheng, N., He, R., Tian, J., Ye, P. P. and Ye, R. D., Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008. 181: 22-26.
25. He, R. L., Zhou, J., Hanson, C. Z., Chen, J., Cheng, N. and Ye, R. D., Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 2009. 113: 429-437.
26. Kim, J. S., Ryoo, S. B., Heo, K., Kim, J. G., Son, T. G., Moon, C. and Yang, K., Attenuating effects of granulocyte-colony stimulating factor (G-CSF) in radiation induced intestinal injury in mice. Food Chem. Toxicol. 2012. 50: 3174-3180.
27. He, R., Sang, H. and Ye, R. D., Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003. 101: 1572-1581.
28. He, R., Shepard, L. W., Chen, J., Pan, Z. K. and Ye, R. D., Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J. Immunol. 2006. 177: 4072-4079.
29. Lee, H. Y., Kim, M. K., Park, K. S., Shin, E. H., Jo, S. H., Kim, S. D., Jo, E. J. et al., Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes. Mol. Pharmacol. 2006. 70: 241-248.
30. Le, Y., Gong, W., Li, B., Dunlop, N. M., Shen, W., Su, S. B., Ye, R. D. et al., Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 1999. 163: 6777-6784.
31. Bae, Y. S., Lee, H. Y., Jo, E. J., Kim, J. I., Kang, H. K., Ye, R. D., Kwak, J. Y. et al., Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 2004. 173: 607-614.
32. Lin, R., Génin, P., Mamane, Y. and Hiscott, J., Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 2000. 20: 6342-6353.
33. Ali, S., Mohs, A., Thomas, M., Klare, J., Ross, R., Schmitz, M. L. and Martin, M. U., The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J. Immunol. 2011. 187: 1609-1616.
34. Choi, Y. S., Park, J. A., Kim, J., Rho, S. S., Park, H., Kim, Y. M. and Kwon, Y. G., Nuclear IL-33 is a transcriptional regulator of NF-kappaB p65 and induces endothelial cell activation. Biochem. Biophys. Res. Commun. 2012. 421: 305-311.
35. Niemi, K., Teirila, L., Lappalainen, J., Rajamaki, K., Baumann, M. H., Oorni, K., Wolff, H. et al., Serum amyloid A activates the NLRP3 inflammasome via P2×7 receptor and a cathepsin B-sensitive pathway. J. Immunol. 2011. 186: 6119-6128.
36. Baranova, I. N., Bocharov, A. V., Vishnyakova, T. G., Kurlander, R., Chen, Z., Fu, D., Arias, I. M. et al., CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J. Biol. Chem. 2010. 285: 8492-8506.
37. Chiang, N., Fierro, I. M., Gronert, K. and Serhan, C. N., Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 2000. 191: 1197-1208.
38. Polumuri, S. K., Jayakar, G. G., Shirey, K. A., Roberts, Z. J., Perkins, D. J., Pitha, P. M. and Vogel, S. N., Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J. Immunol. 2012. 189: 50-60.
39. Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J. et al., HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006. 26: 174-179.
40. Chen, K., Le, Y., Liu, Y., Gong, W., Ying, G., Huang, J., Yoshimura, T. et al., A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J. Immunol. 2010. 184: 3331-3335.
41. Zhang, X., Goncalves, R. and Mosser, D. M., The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 2008. 83: 14.1.1-14.1.14.